Janssen Research & Development, L.L.C., a division of Johnson & Johnson's Family of Companies is recruiting for an Associate Scientist to join the Computational Sciences group within Discovery Science, to be based out of Springhouse PA. Up to 10% domestic and international travel is required.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
Janssen Research & Development, LLC discovers and develops innovative medical solutions to address important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Please visit http://www.janssenrnd.com/ for more information.
We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
Janssen Discovery Sciences is supporting transformational research harnessing state-of-the-art multi-parametric platforms and systems analysis of the immune response in preclinical models and clinical studies to identify and evaluate innovative interventions in oncology, pathogenic infections and auto-immune diseases and guide prophylactic and therapeutic vaccine development.
This commitment aims to bridge the gap between the single molecule/single regimen pharmacology and the orchestration of host response in animal models and in the clinic. The goal is to take into consideration the cooperative and cross-talking, non-linear processes of immune cells transitioning in a continuum of states thereby enabling deeper understanding of emergent deleterious or disease resolving behaviors.
Considerable internal investments have been made in mass cytometry, high-content imaging, single cell sequencing with corresponding high-dimensional data analytics that allows for the systematic evaluation of the immune repertoire in the normal and disease state. In addition, we have established a network of key strategic academic partners as key components of our systems immunology strategy.